The highly-anticipated popular American horror-science-fiction series Stranger Things is all set to conclude this year. Ever ...

In a new book, pediatric infectious disease specialist Dr. Adam Ratner details the history of measles, a virus that’s often a ...

For a lot of people, there’s nothing more “holistic” or “natural” than going to an apple orchard and picking their favorite fall fruit themselves. But the truth is, when you shine up that ...

Many in Georgia feel the government is taking the country back into the Kremlin’s orbit. As the protest movement nears its ...

Alternative for Germany appears to be heading for its strongest national election result yet this month and is fielding its ...

The American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress will be held Feb. 28 to March ...

BY DEBBIE PAGE The Mooresville Graded School District Board of Education heard plans for the summer enrichment and retesting ...

The best kind of visit with an old friend is one that feels like, no matter how much time has passed, you still really, truly ...

If you’ve been on the internet recently, you’ve likely encountered Bryan Johnson’s meticulously optimized, data-driven quest ...

Starmer faces new £24bn tariff threat as Trump rages over VAT - Trump ‘is not willing to tolerate’ VAT, US president’s trade ...

Taking baby steps, you request five names, with two words in the name, and then—not to be overly original—you type "anna" and ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.